Company: JUPGF
Filing Date: 2025-07-01
Form Type: DRS/A
Source: 0001641172-25-017223
Chunk: 42

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-07-01
Form: DRS/A
Chunk 42
---
1300 with respect to our natural graphite project in Minas Gerais state (the “Malacacheta Project”); |
| (3) | An                                                                                                                                                              
 expected allocation of up to $8,000,000 to pay the exercise price of the Option to Atlas Lithium in the event Atlas Lithium elects                              
 to receive all or a portion of the exercise price of the Option in cash rather than shares of common stock; and                                                 |
| (4) | Any                                                                                                                                                             
 surplus funds, or any funds available due to the exercise price of the Option to Atlas Lithium not being paid entirely in cash, if                              
 any, shall be used for general working capital purposes and as cash reserves.                                                                                   |

The expected use of net proceeds of this offering as listed above represents our current intentions based upon our present plan and business conditions. The actual amounts and timing of our actual use of net proceeds will vary depending on numerous factors, and management shall have broad discretion to modify the above list of priorities as new information is obtained. We have presumed that we will receive aggregate gross proceeds of $[●] from this offering (excluding any proceeds received from exercise of the over-allotment option by the underwriters, if any) and will incur approximately $[●] in offering costs, commissions and fees.

The use of the proceeds listed above represents management’s estimates based upon current business and economic conditions. Although we do not contemplate changes in the proposed use of proceeds, to the extent we find that adjustment is required for other uses by reason of existing business conditions, the use of proceeds may be adjusted. The actual use of the proceeds of this offering could differ materially from those set forth above as a result of several factors including those set forth under “Risk Factors” and elsewhere in this prospectus.

Pending the use of the net proceeds of this offering, we intend to invest the net proceeds in short-term investment-grade, interest-bearing securities.

| 30 |

<div align='center'>DETERMINATION OF OFFERING PRICE</div>

Prior to this offering, there was a limited public market for our common stock. We and the underwriters will determine at what price we may sell the common stock offered by this prospectus. As of [●], 2025, the closing bid price for our common stock as reported on the OTCQB was $[●] per share. The principal factors to be considered when determining the underwritten offering price include:

| ● | our                                                                                                          
 negotiation with the investors;                                                                              |
| ● |